A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
Mayo Clinic Reports Increasing Use of Mastectomy for Early-stage Breast Cancer

According to the results of a study presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO), the number of mastectomies performed for early-stage breast cancer at the Mayo Clinic increased by 13% over a three-year period.1 Increasing use of preoperative magnetic resonance imaging (MRI) may explain some of the increase in mastectomy rates.

In 1990, the National Institutes of Health issued a statement that for most women with Stage I or Stage II breast cancer, breast-conserving therapy (lumpectomy plus radiation therapy) is as effective as mastectomy with respect to overall survival. Since that time breast-conserving therapy has become a standard treatment option for early-stage breast cancer.

A recent study from Brazil has reported that MRI examinations increased mastectomies by 27% in 99 patients treated for breast cancer in 2004-2005.2 These authors attributed this observation to a more accurate determination of local extent of cancer spread by the use of MRI.

Recently, however, researchers at the Mayo Clinic noted an increase in the use of mastectomy for early-stage breast cancer. To evaluate patterns in the use of mastectomy, the researchers conducted a retrospective study of 5,464 women who had surgery for early-stage breast cancer between 1997 and 2006.

  • Mastectomy rates declined from 45% in 1997 to 30% in 2003, but then increased to 43% in 2006.
  • Rates of preoperative MRI increased from 11% in 2003 to 22% in 2006.
  • 52% of women who had preoperative MRI chose a mastectomy, compared with 38% of women who did not have preoperative MRI.
  • Although mastectomy rates were lower in women who did not have preoperative MRI, mastectomy rates also increased in these women between 2003 and 2006.

Comments: This study suggests that preoperative breast MRI may contribute to increased use of mastectomy among women with early-stage breast cancer. Other factors may also be contributing to use of mastectomy, however, such as improvements in breast reconstruction and increasing use of genetic testing.

Related News:

Surgeons not Referring Mastectomy Patients for Reconstructive Surgical Evaluation (04/18/2007)

Reference: 


1 Katipamula R, Hoskin TL, Boughey JC et al. Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and pre-operative MRI. Proceedings from the 44th annual meeting of the American Society of Clinical Oncology. Chicago, IL. 2008. Abstract #509.

2 Mameri CSm Kemp C, Goldman SM, et al. Breast Journal. 2008;14:236-234.

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
Maintenance Rituxan® Is Safe for Follicular Lymphoma (7/8/2008)

Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed NHL (6/27/2008)

Lumiliximab and FCR Promising for Relapsed CLL (6/26/2008)

Flavopiridol Has Significant Activity in Relapsed Chronic Lymphocytic Leukemia (6/25/2008)

Sprycel® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Tasigna® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Patients with KRAS Mutation Do Not Benefit from EGFR Inhibitors (6/20/2008)

Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer (6/20/2008)

Does a 10-year 10% Continuous Complete Remission Rate for Myeloma Patients Suggest Cure? (6/19/2008)

Radiation Therapy for Prostate Cancer Increases Incidence of AML (6/18/2008)

Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia (6/17/2008)

Statins May Reduce Acute Graft-versus-host Disease (6/17/2008)

Provigil®, a Eugeroic Agent, Improves Severe Cancer-related Fatigue (6/13/2008)

Results of Treating NHL Patients over the Age of 80 Reported at ASCO (6/12/2008)

Single-dose Carboplatin Confirmed as Effective as Radiation Therapy for Stage I Seminoma (6/12/2008)

Dose-dense Chemotherapy Effective for Localized Ewing’s Sarcoma (6/11/2008)

Mayo Clinic Reports Increasing Use of Mastectomy for Early-stage Breast Cancer (6/11/2008)

Brachytherapy May Be Treatment of Choice for Endometrial Cancer (6/10/2008)

Gemzar® Improves Survival in Early Pancreatic Cancer (6/9/2008)

Addition of Tykerb® to Herceptin® Improves Time to Progression in Herceptin Pre-treated Breast Cancer (6/6/2008)

Addition of Avastin® to Taxotere® Improves Progression-free Survival in Advanced HER2-negative Breast Cancer (6/6/2008)

Nexavar® Delays Progression of Heavily Pre-treated NSCLC (6/6/2008)

Acupuncture Reduces Pain after Neck Dissection (6/6/2008)

VePesid®/Platinol® Remains Standard of Care for Small Cell Lung Cancer (6/6/2008)

Blood Test Shows Promise for Early Detection of Lung Cancer (6/6/2008)

Tykerb® Monotherapy Active in HER2-positive Refractory Inflammatory Breast Cancer (6/6/2008)

CDX-110 Vaccine May Improve Survival in Brain Cancer (6/5/2008)

Sites of Relapse in Breast Cancer May Require Biopsy to Accurately Determine HER2 or Hormone Status (6/5/2008)

Study Confirms Efficacy of Sutent® for Initial Treatment of Metastatic Renal Cell Cancer (6/4/2008)

Conventional Chemotherapy Outperforms Xeloda® in Older Breast Cancer Patients (6/4/2008)




© 1998-2007 CancerConsultants.com  All Rights Reserved.